Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CELL BASED ASSAYS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL CELL BASED ASSAYS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CELL BASED ASSAYS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTAL ANALYSIS
5.2 PORTER’S FIVE FORCES
6 INDUSTRY INSIGHTS
7 REGULATORY FRAMWORK
8 GLOBAL CELL BASED ASSAYS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 CONSUMABLES
8.2.1 REAGENTS
8.2.1.1. MARKET VALUE (USD MILLION)
8.2.1.2. MARKET VOLUME (UNITS)
8.2.1.3. AVERAGE SELLING PRICE (USD)
8.2.2 PROBES & LABELS
8.2.2.1. MARKET VALUE (USD MILLION)
8.2.2.2. MARKET VOLUME (UNITS)
8.2.2.3. AVERAGE SELLING PRICE (USD)
8.2.3 ASSAY KITS
8.2.3.1. REPORTER GENE ASSAYS
8.2.3.1.1. MARKET VALUE (USD MILLION)
8.2.3.1.2. MARKET VOLUME (UNITS)
8.2.3.1.3. AVERAGE SELLING PRICE (USD)
8.2.3.2. CELL VIABILITY ASSAY
8.2.3.2.1. MARKET VALUE (USD MILLION)
8.2.3.2.2. MARKET VOLUME (UNITS)
8.2.3.2.3. AVERAGE SELLING PRICE (USD)
8.2.3.3. CYTOTOXICITY ASSAY
8.2.3.3.1. MARKET VALUE (USD MILLION)
8.2.3.3.2. MARKET VOLUME (UNITS)
8.2.3.3.3. AVERAGE SELLING PRICE (USD)
8.2.3.4. CELL PROLIFERATION ASSAYS
8.2.3.4.1. MARKET VALUE (USD MILLION)
8.2.3.4.2. MARKET VOLUME (UNITS)
8.2.3.4.3. AVERAGE SELLING PRICE (USD)
8.2.3.5. SECOND MESSENGER ASSAYS
8.2.3.5.1. MARKET VALUE (USD MILLION)
8.2.3.5.2. MARKET VOLUME (UNITS)
8.2.3.5.3. AVERAGE SELLING PRICE (USD)
8.2.3.6. CELL DEATH ASSAYS
8.2.3.6.1. MARKET VALUE (USD MILLION)
8.2.3.6.2. MARKET VOLUME (UNITS)
8.2.3.6.3. AVERAGE SELLING PRICE (USD)
8.2.3.7. CELL SENESCENCE ASSAYS
8.2.3.7.1. MARKET VALUE (USD MILLION)
8.2.3.7.2. MARKET VOLUME (UNITS)
8.2.3.7.3. AVERAGE SELLING PRICE (USD)
8.2.3.8. CELL SIGNALING ASSAYS
8.2.3.8.1. MARKET VALUE (USD MILLION)
8.2.3.8.2. MARKET VOLUME (UNITS)
8.2.3.8.3. AVERAGE SELLING PRICE (USD)
8.2.3.9. OTHER ASSAY KITS
8.2.4 CELL LINES
8.2.4.1. IMMORTALIZED CELL LINES
8.2.4.1.1. MARKET VALUE (USD MILLION)
8.2.4.1.2. MARKET VOLUME (UNITS)
8.2.4.1.3. AVERAGE SELLING PRICE (USD)
8.2.4.2. PRIMARY CELL LINES
8.2.4.2.1. MARKET VALUE (USD MILLION)
8.2.4.2.2. MARKET VOLUME (UNITS)
8.2.4.2.3. AVERAGE SELLING PRICE (USD)
8.2.4.3. STEM CELL LINES
8.2.4.3.1. MARKET VALUE (USD MILLION)
8.2.4.3.2. MARKET VOLUME (UNITS)
8.2.4.3.3. AVERAGE SELLING PRICE (USD)
8.2.4.4. OTHER CELL LINES
8.2.5 OTHER CONSUMABLES
8.3 INSTRUMENTS
8.3.1 MICROPLATES
8.3.1.1. MARKET VALUE (USD MILLION)
8.3.1.2. MARKET VOLUME (UNITS)
8.3.1.3. AVERAGE SELLING PRICE (USD)
8.3.2 MICROPLATE READERS
8.3.2.1. MARKET VALUE (USD MILLION)
8.3.2.2. MARKET VOLUME (UNITS)
8.3.2.3. AVERAGE SELLING PRICE (USD)
8.3.3 HIGH THROUGHPUT SCREENING
8.3.3.1. MARKET VALUE (USD MILLION)
8.3.3.2. MARKET VOLUME (UNITS)
8.3.3.3. AVERAGE SELLING PRICE (USD)
8.3.4 LIQUID HANDLING SYSTEMS
8.3.4.1. MARKET VALUE (USD MILLION)
8.3.4.2. MARKET VOLUME (UNITS)
8.3.4.3. AVERAGE SELLING PRICE (USD)
8.3.5 OTHER INSTRUMENTS
8.4 SOFTWARE & SERVICES
9 GLOBAL CELL BASED ASSAYS MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 AUTOMATED HANDLING
9.3 FLOW CYTOMETRY
9.4 LABEL-FREE DETECTION
9.5 HIGH-THROUGHPUT SCREENING
9.6 OTHER TECHNOLOGIES
10 GLOBAL CELL BASED ASSAYS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 DRUG DISCOVERY
10.2.1 TOXICITY STUDIES
10.2.1.1. CONSUMABLES
10.2.1.2. INSTRUMENTS
10.2.1.3. SOFTWARE & SERVICES
10.2.2 PHARMACODYNAMIC STUDIES
10.2.2.1. CONSUMABLES
10.2.2.2. INSTRUMENTS
10.2.2.3. SOFTWARE & SERVICES
10.2.3 PHARMACOKINETIC STUDIES
10.2.3.1. CONSUMABLES
10.2.3.2. INSTRUMENTS
10.2.3.3. SOFTWARE & SERVICES
10.3 LIFE SCIENCE RESEARCH
10.3.1 CONSUMABLES
10.3.2 INSTRUMENTS
10.3.3 SOFTWARE & SERVICES
10.4 ADME STUDIES
10.4.1 CONSUMABLES
10.4.2 INSTRUMENTS
10.4.3 SOFTWARE & SERVICES
10.5 PREDICTIVE TOXICOLOGY
10.5.1 CONSUMABLES
10.5.2 INSTRUMENTS
10.5.3 SOFTWARE & SERVICES
10.6 OTHER APPLICATIONS
11 GLOBAL CELL BASED ASSAYS MARKET, BY END USER
11.1 OVERVIEW
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
11.4 CONTRACT RESEARCH ORGANIZATION
11.5 OTHERS
12 GLOBAL CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDERS
12.3 RETAIL SALES
12.4 OTHERS
13 GLOBAL CELL BASED ASSAYS MARKET, BY COUNTRY
Global CELL BASED ASSAYS Market (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.1.1. U.S. CELL BASED ASSAYS MARKET, BY PRODUCT TYPE
13.1.1.2. U.S. CELL BASED ASSAYS MARKET, BY TECHNOLOGY
13.1.1.3. U.S. CELL BASED ASSAYS MARKET, BY APPLICATION
13.1.1.4. U.S. CELL BASED ASSAYS MARKET, BY END USER
13.1.1.5. U.S. CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL
13.1.2 CANADA
13.1.3 MEXICO
13.2 EUROPE
13.2.1 GERMANY
13.2.2 FRANCE
13.2.3 U.K.
13.2.4 ITALY
13.2.5 SPAIN
13.2.6 RUSSIA
13.2.7 TURKEY
13.2.8 BELGIUM
13.2.9 NETHERLANDS
13.2.10 SWITZERLAND
13.2.11 REST OF EUROPE
13.3 ASIA-PACIFIC
13.3.1 JAPAN
13.3.2 CHINA
13.3.3 SOUTH KOREA
13.3.4 INDIA
13.3.5 AUSTRALIA
13.3.6 SINGAPORE
13.3.7 THAILAND
13.3.8 MALAYSIA
13.3.9 INDONESIA
13.3.10 PHILIPPINES
13.3.11 REST OF ASIA-PACIFIC
13.4 SOUTH AMERICA
13.4.1 BRAZIL
13.4.2 ARGENTINA
13.4.3 REST OF SOUTH AMERICA
13.5 MIDDLE EAST AND AFRICA
13.5.1 SOUTH AFRICA
13.5.2 SAUDI ARABIA
13.5.3 UAE
13.5.4 EGYPT
13.5.5 ISRAEL
13.5.6 REST OF MIDDLE EAST AND AFRICA
13.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
14 GLOBAL CELL BASED ASSAYS MARKET, SWOT AND DBR ANALYSIS
15 GLOBAL CELL BASED ASSAYS MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: EUROPE
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15.5 MERGERS & ACQUISITIONS
15.6 NEW PRODUCT DEVELOPMENT & APPROVALS
15.7 EXPANSIONS
15.8 REGULATORY CHANGES
15.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
16 GLOBAL CELL BASED ASSAYS MARKET, COMPANY PROFILE
16.1 THERMO FISHER SCIENTIFIC
16.1.1 COMPANY OVERVIEW
16.1.2 REVENUE ANALYSIS
16.1.3 GEOGRAPHIC PRESENCE
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 MERCK KGAA
16.2.1 COMPANY OVERVIEW
16.2.2 REVENUE ANALYSIS
16.2.3 GEOGRAPHIC PRESENCE
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 BD
16.3.1 COMPANY OVERVIEW
16.3.2 REVENUE ANALYSIS
16.3.3 GEOGRAPHIC PRESENCE
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 PERKINELMER, INC.
16.4.1 COMPANY OVERVIEW
16.4.2 REVENUE ANALYSIS
16.4.3 GEOGRAPHIC PRESENCE
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 PROMEGA CORPORATION
16.5.1 COMPANY OVERVIEW
16.5.2 REVENUE ANALYSIS
16.5.3 GEOGRAPHIC PRESENCE
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 CHARLES RIVER LABORATORIES
16.6.1 COMPANY OVERVIEW
16.6.2 REVENUE ANALYSIS
16.6.3 GEOGRAPHIC PRESENCE
16.6.4 PRODUCT PORTFOLIO
16.6.5 RECENT DEVELOPMENTS
16.7 LONZA
16.7.1 COMPANY OVERVIEW
16.7.2 REVENUE ANALYSIS
16.7.3 GEOGRAPHIC PRESENCE
16.7.4 PRODUCT PORTFOLIO
16.7.5 RECENT DEVELOPMENTS
16.8 BIOAGILYTIX LABS.
16.8.1 COMPANY OVERVIEW
16.8.2 REVENUE ANALYSIS
16.8.3 GEOGRAPHIC PRESENCE
16.8.4 PRODUCT PORTFOLIO
16.8.5 RECENT DEVELOPMENTS
16.9 REACTION BIOLOGY CORPORATION
16.9.1 COMPANY OVERVIEW
16.9.2 REVENUE ANALYSIS
16.9.3 GEOGRAPHIC PRESENCE
16.9.4 PRODUCT PORTFOLIO
16.9.5 RECENT DEVELOPMENTS
16.1 AAT BIOQUEST
16.10.1 COMPANY OVERVIEW
16.10.2 REVENUE ANALYSIS
16.10.3 GEOGRAPHIC PRESENCE
16.10.4 PRODUCT PORTFOLIO
16.10.5 RECENT DEVELOPMENTS
16.11 CORNING INCORPORATED
16.11.1 COMPANY OVERVIEW
16.11.2 REVENUE ANALYSIS
16.11.3 GEOGRAPHIC PRESENCE
16.11.4 PRODUCT PORTFOLIO
16.11.5 RECENT DEVELOPMENTS
16.12 ENZO LIFE SCIENCES, INC.
16.12.1 COMPANY OVERVIEW
16.12.2 REVENUE ANALYSIS
16.12.3 GEOGRAPHIC PRESENCE
16.12.4 PRODUCT PORTFOLIO
16.12.5 RECENT DEVELOPMENTS
16.13 BMG LABTECH
16.13.1 COMPANY OVERVIEW
16.13.2 REVENUE ANALYSIS
16.13.3 GEOGRAPHIC PRESENCE
16.13.4 PRODUCT PORTFOLIO
16.13.5 RECENT DEVELOPMENTS
16.14 BIOCAT GMBH
16.14.1 COMPANY OVERVIEW
16.14.2 REVENUE ANALYSIS
16.14.3 GEOGRAPHIC PRESENCE
16.14.4 PRODUCT PORTFOLIO
16.14.5 RECENT DEVELOPMENTS
16.15 IMMUNOLOGIX
16.15.1 COMPANY OVERVIEW
16.15.2 REVENUE ANALYSIS
16.15.3 GEOGRAPHIC PRESENCE
16.15.4 PRODUCT PORTFOLIO
16.15.5 RECENT DEVELOPMENTS
16.16 DANAHER
16.16.1 COMPANY OVERVIEW
16.16.2 REVENUE ANALYSIS
16.16.3 GEOGRAPHIC PRESENCE
16.16.4 PRODUCT PORTFOLIO
16.16.5 RECENT DEVELOPMENTS
16.17 GENERAL ELECTRIC
16.17.1 COMPANY OVERVIEW
16.17.2 REVENUE ANALYSIS
16.17.3 GEOGRAPHIC PRESENCE
16.17.4 PRODUCT PORTFOLIO
16.17.5 RECENT DEVELOPMENTS
16.18 CELL BIOLABS, INC.
16.18.1 COMPANY OVERVIEW
16.18.2 REVENUE ANALYSIS
16.18.3 GEOGRAPHIC PRESENCE
16.18.4 PRODUCT PORTFOLIO
16.18.5 RECENT DEVELOPMENTS
16.19 EUROFINS SCIENTIFIC
16.19.1 COMPANY OVERVIEW
16.19.2 REVENUE ANALYSIS
16.19.3 GEOGRAPHIC PRESENCE
16.19.4 PRODUCT PORTFOLIO
16.19.5 RECENT DEVELOPMENTS
16.2 F. HOFFMANN-LA ROCHE LTD
16.20.1 COMPANY OVERVIEW
16.20.2 REVENUE ANALYSIS
16.20.3 GEOGRAPHIC PRESENCE
16.20.4 PRODUCT PORTFOLIO
16.20.5 RECENT DEVELOPMENTS
16.21 STEMCELL TECHNOLOGIES INC.
16.21.1 COMPANY OVERVIEW
16.21.2 REVENUE ANALYSIS
16.21.3 GEOGRAPHIC PRESENCE
16.21.4 PRODUCT PORTFOLIO
16.21.5 RECENT DEVELOPMENTS
16.22 READYCELL, S.L.
16.22.1 COMPANY OVERVIEW
16.22.2 REVENUE ANALYSIS
16.22.3 GEOGRAPHIC PRESENCE
16.22.4 PRODUCT PORTFOLIO
16.22.5 RECENT DEVELOPMENTS
16.23 SARTORIUS AG
16.23.1 COMPANY OVERVIEW
16.23.2 REVENUE ANALYSIS
16.23.3 GEOGRAPHIC PRESENCE
16.23.4 PRODUCT PORTFOLIO
16.23.5 RECENT DEVELOPMENTS
16.24 ACEL,INC
16.24.1 COMPANY OVERVIEW
16.24.2 REVENUE ANALYSIS
16.24.3 GEOGRAPHIC PRESENCE
16.24.4 PRODUCT PORTFOLIO
16.24.5 RECENT DEVELOPMENTS
16.25 IBIDI GMBH
16.25.1 COMPANY OVERVIEW
16.25.2 REVENUE ANALYSIS
16.25.3 GEOGRAPHIC PRESENCE
16.25.4 PRODUCT PORTFOLIO
16.25.5 RECENT DEVELOPMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST RELATED REPORTS
17 CONCLUSION
18 QUESTIONNAIRE
19 ABOUT DATA BRIDGE MARKET RESEARCH
